Page last updated: 2024-08-21

aminoimidazole carboxamide and Multiple Sclerosis

aminoimidazole carboxamide has been researched along with Multiple Sclerosis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Giri, S; Nath, N; Prasad, R; Salem, ML; Singh, AK; Singh, I	1
Paintlia, AS; Paintlia, MK; Singh, AK; Singh, I	1

Other Studies

2 other study(ies) available for aminoimidazole carboxamide and Multiple Sclerosis

Article	Year
5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis. Journal of immunology (Baltimore, Md. : 1950), 2005, Jul-01, Volume: 175, Issue:1 Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Antigen Presentation; Cytokines; DNA-Binding Proteins; Encephalomyelitis, Autoimmune, Experimental; Enzyme Activation; Female; GATA3 Transcription Factor; Glycoproteins; Humans; Immunologic Factors; Interleukin-10; Mice; Mice, Inbred C57BL; Multienzyme Complexes; Multiple Sclerosis; Myelin Proteolipid Protein; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Protein Serine-Threonine Kinases; Ribonucleotides; T-Box Domain Proteins; Th1 Cells; Th2 Cells; Trans-Activators; Transcription Factors	2005
Immunomodulatory effect of combination therapy with lovastatin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside alleviates neurodegeneration in experimental autoimmune encephalomyelitis. The American journal of pathology, 2006, Volume: 169, Issue:3 Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Enzyme Activation; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Immunoglobulin G; Immunologic Factors; Lovastatin; Multienzyme Complexes; Multiple Sclerosis; Myelin Basic Protein; Protein Serine-Threonine Kinases; Rats; Rats, Inbred Lew; Ribonucleotides; Th1 Cells; Th2 Cells	2006

Article

Year

5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis.

Journal of immunology (Baltimore, Md. : 1950), 2005, Jul-01, Volume: 175, Issue:1

Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Antigen Presentation; Cytokines; DNA-Binding Proteins; Encephalomyelitis, Autoimmune, Experimental; Enzyme Activation; Female; GATA3 Transcription Factor; Glycoproteins; Humans; Immunologic Factors; Interleukin-10; Mice; Mice, Inbred C57BL; Multienzyme Complexes; Multiple Sclerosis; Myelin Proteolipid Protein; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Protein Serine-Threonine Kinases; Ribonucleotides; T-Box Domain Proteins; Th1 Cells; Th2 Cells; Trans-Activators; Transcription Factors

2005

Immunomodulatory effect of combination therapy with lovastatin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside alleviates neurodegeneration in experimental autoimmune encephalomyelitis.

The American journal of pathology, 2006, Volume: 169, Issue:3

Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Enzyme Activation; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Immunoglobulin G; Immunologic Factors; Lovastatin; Multienzyme Complexes; Multiple Sclerosis; Myelin Basic Protein; Protein Serine-Threonine Kinases; Rats; Rats, Inbred Lew; Ribonucleotides; Th1 Cells; Th2 Cells

2006